ArticleJMIR research protocols2025
Centenarian Mortality Rate During COVID-19: Protocol for a Systematic Review and Meta-Analysis.
Article in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMarked by high mortality rates on a global scale, with disease mortality being notably focused among older adults, the COVID-19 pandemic has become a significant health crisis. Despite the numerous publications on COVID-19 mortality among older adults, there is still a gap in knowledge when considering centenarians, as there is no systematic review and meta-analysis that summarizes COVID-19 mortality in centenarians globally.
objectiveThis study aims to systematically review and synthesize global evidence on COVID-19 mortality rates among centenarians and the population of older adults worldwide, whether residing in long-term health facilities, hospitals, or their homes.
methodsAn automated search was conducted on the following databases: PubMed, Scopus, and Web of Science. Observational studies, both cohort and case-control, were selected. Quality assessment of the selected studies was based on the Joanna Briggs Institute critical appraisal tool for observational cohort and case-control studies. Three independent authors conducted the searches, and any possible disagreements were resolved by consensus. A meta-analysis of mortality proportions will be conducted to calculate the raw, logit, and arcsine proportions for all studies included in our meta-analyses. Heterogeneity between studies with a significance of P=.05 will be assessed by calculating the I
resultsA total of 4 studies were included in our systematic review and meta-analysis. Of the included studies, 3 are retrospective cohort studies and 1 is an observational, retrospective case-control study. As for study group size, 1 cohort study was conducted on a population of less than 1000 participants, 2 studies (1 cohort and 1 case-control) involved more than 10,000 participants, and 1 cohort study included more than 6 million participants.
conclusionsThis study has significant potential. Given the consensus that older adults, let alone centenarians, are the most vulnerable demographic to serious outcomes and deaths during pandemics. Addressing these gaps is crucial for the informed development of public policies, enabling countries to minimize the impacts on this population, particularly during health crises such as the COVID-19 pandemic.
trial registrationPROSPERO CRD42025645150; https://www.crd.york.ac.uk/PROSPERO/view/CRD42025645150. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/74068.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.